HKTVmall首批3,000盒口罩4月13日起開放抽籤登記 每盒30片售價65元
香港電視(01137.HK)旗下HKTVmall公布口罩登記抽籤安排,口罩經SGS測試符合美國ASTM標準Level 2,BFE、PFE、VFE≧98%,每盒30片,售價65元,每5片會有獨立包裝。
首次開賣會以「先登記抽籤,中籤後購買」形式隨機抽出3,000人購買口罩,每人限購一盒,登記日期為4月13日早上9時至4月19日晚上11時59分,開放予所有持有有效香港流動電話號碼人士登記,登記時需輸入手機號碼及電郵,毋須使用HKTVmall帳戶都可參加,公司將透過手機短訊通知中籤者,並於4月27日至5月3日購買,登記網址為https://hktvmall.azureedge.net/。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.